Copyright Reports & Markets. All rights reserved.

Global Binge Eating Disorder Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Binge Eating Disorder Drug

      • 1.1 Definition of Binge Eating Disorder Drug
      • 1.2 Binge Eating Disorder Drug Segment by Type
        • 1.2.1 Global Binge Eating Disorder Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Antidepressants
        • 1.2.3 Anticonvulsants
        • 1.2.4 Anti-obesity Medications
      • 1.3 Binge Eating Disorder Drug Segment by Applications
        • 1.3.1 Global Binge Eating Disorder Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Retail Pharmacies
        • 1.3.3 Hospital Pharmacies
        • 1.3.4 Online Pharmacies
      • 1.4 Global Binge Eating Disorder Drug Overall Market
        • 1.4.1 Global Binge Eating Disorder Drug Revenue (2014-2025)
        • 1.4.2 Global Binge Eating Disorder Drug Production (2014-2025)
        • 1.4.3 North America Binge Eating Disorder Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Binge Eating Disorder Drug Status and Prospect (2014-2025)
        • 1.4.5 China Binge Eating Disorder Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Binge Eating Disorder Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Binge Eating Disorder Drug Status and Prospect (2014-2025)
        • 1.4.8 India Binge Eating Disorder Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Binge Eating Disorder Drug
      • 2.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
      • 2.4 Industry Chain Structure of Binge Eating Disorder Drug

      3 Development and Manufacturing Plants Analysis of Binge Eating Disorder Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Binge Eating Disorder Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Binge Eating Disorder Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Binge Eating Disorder Drug Production and Capacity Analysis
      • 4.2 Binge Eating Disorder Drug Revenue Analysis
      • 4.3 Binge Eating Disorder Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Binge Eating Disorder Drug Regional Market Analysis

      • 5.1 Binge Eating Disorder Drug Production by Regions
        • 5.1.1 Global Binge Eating Disorder Drug Production by Regions
        • 5.1.2 Global Binge Eating Disorder Drug Revenue by Regions
      • 5.2 Binge Eating Disorder Drug Consumption by Regions
      • 5.3 North America Binge Eating Disorder Drug Market Analysis
        • 5.3.1 North America Binge Eating Disorder Drug Production
        • 5.3.2 North America Binge Eating Disorder Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Binge Eating Disorder Drug Import and Export
      • 5.4 Europe Binge Eating Disorder Drug Market Analysis
        • 5.4.1 Europe Binge Eating Disorder Drug Production
        • 5.4.2 Europe Binge Eating Disorder Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Binge Eating Disorder Drug Import and Export
      • 5.5 China Binge Eating Disorder Drug Market Analysis
        • 5.5.1 China Binge Eating Disorder Drug Production
        • 5.5.2 China Binge Eating Disorder Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Binge Eating Disorder Drug Import and Export
      • 5.6 Japan Binge Eating Disorder Drug Market Analysis
        • 5.6.1 Japan Binge Eating Disorder Drug Production
        • 5.6.2 Japan Binge Eating Disorder Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Binge Eating Disorder Drug Import and Export
      • 5.7 Southeast Asia Binge Eating Disorder Drug Market Analysis
        • 5.7.1 Southeast Asia Binge Eating Disorder Drug Production
        • 5.7.2 Southeast Asia Binge Eating Disorder Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Binge Eating Disorder Drug Import and Export
      • 5.8 India Binge Eating Disorder Drug Market Analysis
        • 5.8.1 India Binge Eating Disorder Drug Production
        • 5.8.2 India Binge Eating Disorder Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Binge Eating Disorder Drug Import and Export

      6 Binge Eating Disorder Drug Segment Market Analysis (by Type)

      • 6.1 Global Binge Eating Disorder Drug Production by Type
      • 6.2 Global Binge Eating Disorder Drug Revenue by Type
      • 6.3 Binge Eating Disorder Drug Price by Type

      7 Binge Eating Disorder Drug Segment Market Analysis (by Application)

      • 7.1 Global Binge Eating Disorder Drug Consumption by Application
      • 7.2 Global Binge Eating Disorder Drug Consumption Market Share by Application (2014-2019)

      8 Binge Eating Disorder Drug Major Manufacturers Analysis

      • 8.1 Roche
        • 8.1.1 Roche Binge Eating Disorder Drug Production Sites and Area Served
        • 8.1.2 Roche Product Introduction, Application and Specification
        • 8.1.3 Roche Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Chronos Therapeutics
        • 8.2.1 Chronos Therapeutics Binge Eating Disorder Drug Production Sites and Area Served
        • 8.2.2 Chronos Therapeutics Product Introduction, Application and Specification
        • 8.2.3 Chronos Therapeutics Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Heptares
        • 8.3.1 Heptares Binge Eating Disorder Drug Production Sites and Area Served
        • 8.3.2 Heptares Product Introduction, Application and Specification
        • 8.3.3 Heptares Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novo Nordisk
        • 8.4.1 Novo Nordisk Binge Eating Disorder Drug Production Sites and Area Served
        • 8.4.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.4.3 Novo Nordisk Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Omeros Corp
        • 8.5.1 Omeros Corp Binge Eating Disorder Drug Production Sites and Area Served
        • 8.5.2 Omeros Corp Product Introduction, Application and Specification
        • 8.5.3 Omeros Corp Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sunovion Pharmaceuticals
        • 8.6.1 Sunovion Pharmaceuticals Binge Eating Disorder Drug Production Sites and Area Served
        • 8.6.2 Sunovion Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Opiant Pharmaceuticals
        • 8.7.1 Opiant Pharmaceuticals Binge Eating Disorder Drug Production Sites and Area Served
        • 8.7.2 Opiant Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Binge Eating Disorder Drug Market

      • 9.1 Global Binge Eating Disorder Drug Market Trend Analysis
        • 9.1.1 Global Binge Eating Disorder Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Binge Eating Disorder Drug Regional Market Trend
        • 9.2.1 North America Binge Eating Disorder Drug Forecast 2019-2025
        • 9.2.2 Europe Binge Eating Disorder Drug Forecast 2019-2025
        • 9.2.3 China Binge Eating Disorder Drug Forecast 2019-2025
        • 9.2.4 Japan Binge Eating Disorder Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Binge Eating Disorder Drug Forecast 2019-2025
        • 9.2.6 India Binge Eating Disorder Drug Forecast 2019-2025
      • 9.3 Binge Eating Disorder Drug Market Trend (Product Type)
      • 9.4 Binge Eating Disorder Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Binge Eating Disorder Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.

        The global Binge Eating Disorder Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Binge Eating Disorder Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Binge Eating Disorder Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Binge Eating Disorder Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Binge Eating Disorder Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Roche
        Chronos Therapeutics
        Heptares
        Novo Nordisk
        Omeros Corp
        Sunovion Pharmaceuticals
        Opiant Pharmaceuticals
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Antidepressants
        Anticonvulsants
        Anti-obesity Medications

        Segment by Application
        Retail Pharmacies
        Hospital Pharmacies
        Online Pharmacies

        Buy now